Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.10.0.1
Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of Effect of Adoption of ASC Topic 606 on Condensed Consolidated Balance Sheet and Statement of Operations

The following tables present the effect of the adoption of ASC Topic 606 on our condensed consolidated balance sheet and revenue as of and for the six months ended June 30, 2018:

 

Consolidated Balance Sheet:

 

 

    June 30, 2018  
          (unaudited)        
    As reported     Balances without Adoption of ASC 606     Effect of Change
Higher/(Lower) 		 
Accounts receivable, net   $ 7,647     $ 6,731     $ 916  
Accumulated deficit     (134,410 )     (136,910 )     (2,500 )

 

Revenue:

 

    For the six months ended June 30, 2018  
          (unaudited)        
    As reported     Balances without Adoption of ASC 606     Effect of Change
Higher/(Lower) 		 
Revenue, net   $ 10,310     $ 9,580     $ 730  

Schedule of Other Current Assets

Other current assets consisted of the following as of June 30, 2018 and December 31, 2017:

 

    June 30, 2018     December 31, 2017  
    (unaudited)        
             
Indemnification asset   $ 875     $ 875  
Prepaid assets     556       266  
Other     43       31  
    $ 1,474     $ 1,172  

Schedule of Weighted Average Number of Shares

A reconciliation of the number of shares of common stock used in the calculation of basic and diluted loss per share for the three- and six-month periods ended June 30, 2018 and 2017 is as follows:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
    (unaudited)  
                         
Basic weighted average number of common shares     27,933       9,657       27,894       6,877  
Potential dilutive effect of stock-based awards     -       -       -       -  
Diluted weighted average number of common shares     27,933       9,657       27,894       6,877  

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following outstanding stock-based instruments were excluded from the computation of the effect of dilutive securities on loss per share for the following periods because they would have been anti-dilutive:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2018     2017     2018     2017  
    (unaudited)  
                         
Options     2,256       323       2,256       323  
Stock-settled stock appreciation rights (SARs)     59       85       59       85  
Restricted stock units (RSUs)     220       68       220       68  
Warrants     13,542       17,105       13,542       17,105  
      16,077       17,581       16,077       17,581